
Chinese holding and investment company of Daiichi Sankyo, the Japanese pharmaceutical group headquartered in Tokyo. Oversees the group's Chinese operations, including local manufacturing, sales and marketing of prescription medicines, with a portfolio concentrated in oncology, cardiovascular and metabolic disease and pain management, and supports clinical development and regulatory affairs in China.
会社プロフィールを見る
評価を残す